CCME Global will hold a board meeting on Saturday, August 29, 2026, to consider raising funds through an equity issue and approve its financial results for the fiscal year ended March 31, 2026.

The company, formerly known as Genesis IBRC India Limited, disclosed the agenda pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting aims to evaluate capital structure changes alongside strategic operational updates.

Capital Structure and Fundraising

The primary focus of the meeting includes the potential raising of funds through the issue of equity shares or other eligible securities. This may involve warrants or convertible instruments on a preferential basis, subject to shareholder and regulatory approvals.

Additionally, the board will consider:

• An increase in the authorised share capital.
• Alteration in Clause V of the Memorandum of Association.
• Sub-division of share capital, pending necessary approvals.

Financial Results and Strategic Moves

Directors will review and approve the Directors Report along with relevant annexures for FY26. The agenda also includes the consideration of entity acquisitions and a proposed shift in the company’s registered office.

Annual General Meeting Logistics

The board will fix the date, time, venue, and mode for the upcoming Annual General Meeting (AGM). Related matters include approving the AGM notice, setting cut-off and book closure dates for dividend entitlement, and appointing a scrutinizer and remote e-voting agency.

CCME Global Limited appointed Ms. Ami Oza as an additional independent non-executive director and chairperson of the board effective August 21, 2026.

The company also recorded the resignation of Ms. Ritika Agrawal from the chairperson role, though she continues to serve as an independent non-executive director. The board simultaneously reconstituted its audit, nomination and remuneration, and stakeholder relationship committees.

Board Leadership Changes

Ms. Oza, who holds a Master of Laws degree in business laws from the University of Mumbai, brings over 10 years of post-qualification experience in corporate, commercial, and regulatory laws. Her appointment is for a five-year term, subject to shareholder approval. She will receive sitting fees as agreed between the board and herself.

Ms. Agrawal resigned as chairperson citing proposed realignment of board responsibilities and other business commitments. She confirmed there are no other material reasons for her resignation from the chairperson post.

Committee Reconstitution

The board updated the composition of its key committees following these leadership changes and the earlier demise of Mr. Ashok Chhaganbhai Patel on August 15, 2026.

Audit Committee

Ms. Ritika Agrawal was appointed as the new chairperson of the audit committee. Ms. Ami Oza joined as a member. Ms. Poonam Chaturvedi, managing director, remains a member.

Nomination and Remuneration Committee

Ms. Ritika Agrawal was appointed as chairperson of the nomination and remuneration committee. Ms. Ami Oza serves as a member alongside Mr. Padmanaban Krishnamoorthy, a non-executive director.

Stakeholder Relationship Committee

Ms. Ritika Agrawal was appointed as chairperson of the stakeholder relationship committee. Ms. Ami Oza and Mr. Padmanaban Krishnamoorthy serve as members.

Regulatory Compliance

The disclosures were made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/2025/3762 dated January 30, 2026. The company confirmed that Ms. Oza is not debarred by any regulatory authority and is not disqualified under Section 164 of the Companies Act, 2013.